0001209191-19-050616.txt : 20190925 0001209191-19-050616.hdr.sgml : 20190925 20190925142053 ACCESSION NUMBER: 0001209191-19-050616 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190918 FILED AS OF DATE: 20190925 DATE AS OF CHANGE: 20190925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klopp John Michael CENTRAL INDEX KEY: 0001789348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 191113690 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER, SUITE 351 STREET 2: 300 WASHINGTON STREET CITY: NEWTON STATE: MA ZIP: 02458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 351 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-18 0 0001069308 Acer Therapeutics Inc. ACER 0001789348 Klopp John Michael C/O ACER THERAPEUTICS INC. ONE GATEWAY CENTER, SUITE 351 NEWTON MA 02458 0 1 0 0 Chief Technology Officer Employee Stock Option (right to buy) 3.42 2019-09-18 4 A 0 50000 0.00 A 2029-09-18 Common Stock 50000 50000 D The option vests and becomes exercisable as follows: 50% on 01/01/2021 and 50% on 01/01/2022. /s/ Harry Palmin, Attorney-in-fact 2019-09-25